Patents by Inventor Kevin L. Ross

Kevin L. Ross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240108334
    Abstract: Methods, devices, and systems for controlling a tissue-treatment motion by a surgical instrument are disclosed.
    Type: Application
    Filed: September 30, 2022
    Publication date: April 4, 2024
    Inventors: Frederick E. Shelton, IV, Taylor W. Aronhalt, Michael J. Vendely, Shane R. Adams, Nicholas J. Ross, Matthew D. Cowperthwait, Jason L. Harris, Kevin M. Fiebig, Eric B. LaFay, Jose Luis De Cordoba Matilla, Raymond E. Parfett, Curtis A. Maples, Sarah A. Worthington, Jacqueline C. Aronhalt
  • Publication number: 20240108340
    Abstract: A surgical instrument system comprising a motor system and a control circuit is disclosed. The motor system comprises a motor and a drive train movable by the motor to actuate a firing member through a staple firing stroke. The control circuit is coupled to the motor, wherein, during the staple firing stroke, the control circuit is configured to perform a first sensory action to determine if a speed of the motor can be increased to a first target speed, monitor a result of the first sensory action, adjust a parameter of a subsequent sensory action based on the monitored result of the first sensory action, and perform the subsequent sensory action with the adjusted parameter.
    Type: Application
    Filed: September 30, 2022
    Publication date: April 4, 2024
    Inventors: Frederick E. Shelton, IV, Jason L. Harris, Kevin M. Fiebig, Matthew D. Cowperthwait, Nicholas J. Ross, Shane R. Adams
  • Patent number: 5559207
    Abstract: A method of phosphate ester hydrolysis including incubating a solution of an aqueous phosphate ester with a texaphyrin metal complex. The metal is a metal cation having catalytic activity for ester bond hydrolysis in aqueous solution, in particular, a lanthanide metal cation, preferably Eu(III) or Dy(III). A preferred substrate is RNA and a preferred texaphyrin is a derivatized texaphyrin having binding specificity, in particular, a texaphyrin covalently coupled to a site-directed molecule, preferably an oligonucleotide.
    Type: Grant
    Filed: April 14, 1994
    Date of Patent: September 24, 1996
    Assignees: Board of Regents, University of Texas, Pharmacyclics, Inc.
    Inventors: Jonathan L. Sessler, Daniel A. Smith, Richard A. Miller, Kevin L. Ross, Meredith Wright, William C. Dow, Vladimir A. Kr al, Brent Iverson, Darren Magda